Can depression cause epilepsy according to the American Epilepsy Society?

The research suggests a strong association but does not definitively state that depression causes epilepsy. Shared biological pathways are being explored.

How does depression affect epilepsy treatment?

Depression can make epilepsy harder to treat, with individuals being 40% more likely to not respond well to their first antiseizure medication.

What is the key takeaway from the American Epilepsy Society findings?

The findings highlight the importance of early detection and integrated care between mental health and neurology for both depression and epilepsy.

Home / Health / Depression Doubles Epilepsy Risk

Depression Doubles Epilepsy Risk

8 Dec

•

Summary

Depression increases the risk of developing epilepsy by over two times.
Depression complicates epilepsy treatment, reducing medication effectiveness.
Early detection and coordinated care are vital for both conditions.

A significant connection has been identified between depression and epilepsy, with individuals experiencing depression showing a more than doubled risk of developing epilepsy. This finding, based on a meta-analysis of eight prior studies, highlights a concerning association between mental health and neurological conditions. Researchers emphasize that while this link is strong, it does not confirm depression directly causes epilepsy, but points to shared biological pathways.

Further research indicates that depression not only elevates the risk of developing epilepsy but also complicates its treatment. A separate study found that individuals with epilepsy and depression were 40% more likely to experience treatment failure with their first antiseizure medication. This suggests that depression can negatively impact treatment adherence and effectiveness.

Experts stress the importance of early detection and coordinated care between mental health and neurology professionals. Integrating mental health support into epilepsy treatment plans is crucial for improving patient outcomes, ensuring longer adherence to therapies, and better managing the complexities arising from the co-occurrence of these conditions.